Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ptc Therapeutics (PTCT) Depreciation and Depletion: 2012-2020

Historic Depreciation and Depletion for Ptc Therapeutics (PTCT) over the last 8 years, with Dec 2020 value amounting to -$24.5 million.

  • Ptc Therapeutics' Depreciation and Depletion fell 34.53% to -$24.5 million in Q4 2020 from the same period last year, while for Dec 2020 it was $6.6 million, marking a year-over-year increase of 40.43%. This contributed to the annual value of $14.9 million for FY2024, which is 7.19% up from last year.
  • Ptc Therapeutics' Depreciation and Depletion amounted to -$24.5 million in Q4 2020, which was down 310.32% from $11.6 million recorded in Q3 2020.
  • Ptc Therapeutics' 5-year Depreciation and Depletion high stood at $11.6 million for Q3 2020, and its period low was -$24.5 million during Q4 2020.
  • In the last 3 years, Ptc Therapeutics' Depreciation and Depletion had a median value of $7.1 million in 2018 and averaged $1.2 million.
  • Examining YoY changes over the last 5 years, Ptc Therapeutics' Depreciation and Depletion showed a top increase of 1,166.30% in 2017 and a maximum decrease of 1,247.39% in 2017.
  • Over the past 5 years, Ptc Therapeutics' Depreciation and Depletion (Quarterly) stood at $823,000 in 2016, then tumbled by 1,247.39% to -$9.4 million in 2017, then plummeted by 77.02% to -$16.7 million in 2018, then fell by 8.90% to -$18.2 million in 2019, then tumbled by 34.53% to -$24.5 million in 2020.
  • Its Depreciation and Depletion was -$24.5 million in Q4 2020, compared to $11.6 million in Q3 2020 and $10.2 million in Q2 2020.